New criteria for the susceptibility testing of Ubrolexin® when treating mastitis in dairy cows
Boehringer Ingelheim, a global leader in animal health, announces that Clinical and Laboratory Standards Institute (CLSI)* approved revised interpretive criteria for the susceptibility testing of...

